EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of Vincamine Loaded with Silver Nanoparticles as a New Potential Therapeutic Agent Against Ehrlich’s Solid Carcinoma in Mice

Naief Dahran iD, Mohamed S Othman iD, Mohamed E Ghoniem iD, Mai A Samak iD, Mohamed T Elabbasy iD, Sofian T Obeidat iD, Ghada M Aleid, Shimaa Abo Elnaga, Azza M Khaled, Aya A Altaleb, Ahmed E Abdel Moneim iD

Cells · 2024

DOI: 10.3390/cells13211762 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Naief Dahran und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, College of Medicine, University of Jeddah, Jeddah 21959, Saudi Arabia. Hauptthemen laut MEDLINE: Carcinoma, Ehrlich Tumor, Silver, Metal Nanoparticles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Deanship at University of Ha'il - Saudi Arabia, Scientific Research Deanship fund, University of Ha’il, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vincamine, a monoterpenoid indole alkaloid with vasodilatory properties, is extracted from the leaves of Vinca minor. The present study aimed to determine the potential anticancer effects of vincamine loaded in silver nanoparticles (VCN-AgNPs) in mice with Ehrlich solid carcinoma (ESC). After tumor transplantation, the mice were divided into five groups: ESC, ESC+Cisplatin (CPN; 5 mg/kg), ESC+VCN (40 mg/kg), ESC+AgNPs (6 mg/kg), and ESC+VCN-AgNPs (20 mg/kg). The administration of VCN-AgNPs to ESC-bearing mice improved their survival rate and reduced their body weight, tumor size, and tumor weight compared to the ESC group. Furthermore, VCN-AgNPs intensified oxidative stress in tumor tissues, as evidenced by elevated levels of lipid peroxidation (LPO) and nitric oxide (NO), along with a reduction in the levels of the antioxidants investigated (GSH, GPx, GR, SOD, CAT, and TAC). Furthermore, VCN-AgNPs increased the apoptotic proteins Bax and caspase-3, decreased the anti-apoptotic protein (Bcl-2), increased the inflammatory markers TNF-α and IL-1β, and inhibited angiogenesis by lowering VEGF levels in tumor tissues, all of which led to apoptosis. Furthermore, histopathological studies showed that VCN-AgNPs suppressed the progression of Ehrlich carcinoma and induced the formation of clusters of necrotic and fragmented tumor cells. VCN-AgNPs possess cytotoxic and genotoxic effects against ESC because of their pro-oxidant, pro-apoptotic, pro-inflammatory, and antiangiogenic effects. Additionally, the combination of VCN-AgNPs was more effective and safer than chemically synthesized AgNPs, as indicated by an increase in the lifespan of animals and the total tumor inhibition index.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Ehrlich TumorSilverMetal NanoparticlesAnimalsMiceOxidative StressApoptosisAntioxidantsAntineoplastic AgentsMaleNitric OxideLipid Peroxidation

Stichwörter der Autor:innen

Ehrlich solid carcinomaangiogenesisanticancerapoptosisvincamine

Substanzen

SilverAntioxidantsAntineoplastic AgentsNitric Oxide

Autor:innen und Institutionen

  • Department of Basic Medical Sciences, College of Medicine, University of Jeddah, Jeddah 21959, Saudi Arabia.
  • Biochemistry Department, College of Medicine, University of Ha'il, Ha'il 2440, Saudi Arabia.
  • Faculty of Biotechnology, October University for Modern Science and Arts (MSA), Giza 12566, Egypt.
  • Department of Internal Medicine, College of Medicine, University of Ha'il, Ha'il 2240, Saudi Arabia.
  • Department of Internal Medicine, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt.
  • College of Medicine, University of Ha'il, Ha'il 2240, Saudi Arabia.

ORCID-Profile: Naief Dahran, Mohamed S Othman, Mohamed E Ghoniem, Mai A Samak, Mohamed T Elabbasy, Sofian T Obeidat, Ahmed E Abdel Moneim

Förderung

  • Scientific Research Deanship at University of Ha'il - Saudi Arabia
  • Scientific Research Deanship fund, University of Ha’il, Saudi Arabia

Zitieren

APA

Dahran, N., Othman, M. S., Ghoniem, M. E., Samak, M. A., Elabbasy, M. T., Obeidat, S. T., Aleid, G. M., Abo Elnaga, S., Khaled, A. M., Altaleb, A. A., & Abdel Moneim, A. E. (2024). Evaluation of Vincamine Loaded with Silver Nanoparticles as a New Potential Therapeutic Agent Against Ehrlich’s Solid Carcinoma in Mice. Cells. https://doi.org/10.3390/cells13211762

Vancouver

Dahran N, Othman MS, Ghoniem ME, Samak MA, Elabbasy MT, Obeidat ST, et al. Evaluation of Vincamine Loaded with Silver Nanoparticles as a New Potential Therapeutic Agent Against Ehrlich’s Solid Carcinoma in Mice. Cells. 2024. doi:10.3390/cells13211762

BibTeX
@article{Dahran2024,
  author = {Dahran, Naief and Othman, Mohamed S and Ghoniem, Mohamed E and Samak, Mai A and Elabbasy, Mohamed T and Obeidat, Sofian T and Aleid, Ghada M and Abo Elnaga, Shimaa and Khaled, Azza M and Altaleb, Aya A and Abdel Moneim, Ahmed E},
  title = {Evaluation of Vincamine Loaded with Silver Nanoparticles as a New Potential Therapeutic Agent Against Ehrlich’s Solid Carcinoma in Mice},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13211762}
}
Kostenlos starten →